The newly identified lymphotropic human herpesvirus-6 (HHV-6) is the etiological agent of roseola in children and emerging evidences suggest HHV-6's involvement in fatal hepatitis, acute and chronic hepatitis, persistent lymphadenopathy, acute mononucleosis, pneumonitis, fatal hemophagocytic syndrome and encephalitis. HHV-6 isolates segregate into two groups by their in vitro growth properties, by DNA restriction analyzes and by their reactivities with our HHV-6 monoclonal antibodies [MAbs]. These two groups are tentatively designated as group A and group B. Our studies with sera from healthy adults suggest that individuals may be infected by one or both groups. As yet, isolates cannot be grouped by their disease association. Our preliminary studies show that these two groups are antigenically closely related, yet distinct viruses. Our overall objectives are to define the antigenic cross-reactivity among the two groups of HHV-6 and to develop reagents for an accurate measurement of infection by the two groups. MAbs and human sera reactivities suggest group specific epitopes in two immunogenic glycoproteins, gp82-gp105 of group A and gpl85-gp2l0 of group B. MAbs against gp82-gpl05 neutralized only group A viruses.
Our specific aims of the proposal are: 1. To determine the immunochemical properties of glycoproteins gp82-gpl05 of group A HHV-6 and gpl85-gp2lO of group B HHV-6, to identify and characterize the potential counterparts in the other group, to determine whether these glycoproteins possess exclusively and/or predominantly group specific epitopes and to test the interaction of antibodies against one group with virus and virus infected cells of another group. 2. To identify and sequence the genes coding for these variant glycoproteins and to determine the genetic basis for the variations among the gp82-gplO5 of group A HHV-6 and gpl85-gp2l0 of group B HHV-6. 3. To use MAbs and affinity purified glycoproteins and proteins expressed from cloned genes to evaluate the feasibility of developing assays for the serological differentiation of infection by the two groups of HHV-6. The studies proposed here are significant as they will generate important information about the antigenic cross-reactivity among the HHV-6 groups and an assessment of assays to distinguish infection by the two groups of HHV-6, all of which are essential for a better understanding of HHV-6 epidemiology, association with human diseases and for the eventual development of control measures.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI033502-01
Application #
3148562
Study Section
Experimental Virology Study Section (EVR)
Project Start
1993-05-01
Project End
1996-04-30
Budget Start
1993-05-01
Budget End
1994-04-30
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Kansas
Department
Type
Schools of Medicine
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Chan, S R; Bloomer, C; Chandran, B (1998) Identification and characterization of human herpesvirus-8 lytic cycle-associated ORF 59 protein and the encoding cDNA by monoclonal antibody. Virology 240:118-26
Chandran, B; Bloomer, C; Chan, S R et al. (1998) Human herpesvirus-8 ORF K8.1 gene encodes immunogenic glycoproteins generated by spliced transcripts. Virology 249:140-9
Chandran, B; Smith, M S; Koelle, D M et al. (1998) Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs. Virology 243:208-17
Smith, M S; Bloomer, C; Horvat, R et al. (1997) Detection of human herpesvirus 8 DNA in Kaposi's sarcoma lesions and peripheral blood of human immunodeficiency virus-positive patients and correlation with serologic measurements. J Infect Dis 176:84-93
Koelle, D M; Huang, M L; Chandran, B et al. (1997) Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. J Infect Dis 176:94-102
Pfeiffer, B; Thomson, B; Chandran, B (1995) Identification and characterization of a cDNA derived from multiple splicing that encodes envelope glycoprotein gp105 of human herpesvirus 6. J Virol 69:3490-500
Pfeiffer, B; Berneman, Z N; Neipel, F et al. (1993) Identification and mapping of the gene encoding the glycoprotein complex gp82-gp105 of human herpesvirus 6 and mapping of the neutralizing epitope recognized by monoclonal antibodies. J Virol 67:4611-20